What is Revvity Inc's earnings per share (EPS)?

Revvity Inc (RVTY) reported diluted earnings per share of $2.07 for fiscal year 2025. This represents a -5.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Revvity Inc Financials

RVTY

Trailing 12 months to July 5, 2026

Revenue $2.9B +4.1% YoY

Net Income $237.6M -16.7% YoY

EPS (Diluted) $2.09 -11.4% YoY

Free Cash Flow $558.1M +11.0% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jul 5, 2026 Reported Aug 11, 2026 Currency USD FYE December

Revvity Inc (RVTY) reported $2.9B in revenue over the twelve months to Jul 5, 2026, up 4.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RVTY FY2025 2026-08-11

After its post-2022 reset, Revvity is running as a cash-generative, low-reinvestment business with a slower profit rebuild.

Free cash flow rose from $9.9M in FY2023 to $509M in FY2025 even as net income moved lower, so the company is converting a much larger share of accounting profit into cash than it did two years earlier. Capital intensity helps explain why: FY2025 operating cash flow of $583M only had to cover $74M of capex, leaving room for cash generation without a big revenue rebound.

Long-term debt fell to $2.63B in FY2025 from $3.18B in FY2023, so leverage is being repaired through repayment rather than waiting for growth to do the work. But the current ratio slipped to 1.7x after heavy buybacks, leaving less short-term cushion even as solvency improved.

Goodwill was $6.61B against total assets of $12.17B in FY2025, so more than half of the asset base comes from past acquisitions rather than hard operating assets. That fits the low-capex model: cash demands from physical reinvestment are modest, but reported asset returns are being earned on an acquisition-built balance sheet.

Financial Health Signals

Financial Health Score 52/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Revvity Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Revvity Inc has an operating margin of 12.5%, meaning the company retains $12 of operating profit per $100 of revenue. This strong profitability earns a score of 69/100, reflecting efficient cost management and pricing power. This is down from 12.6% the prior year.

Growth

Revvity Inc's revenue grew a modest 3.7% year-over-year to $2.9B. This slow but positive growth earns a score of 38/100.

Leverage

Revvity Inc has elevated debt relative to equity (D/E of 0.36), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 28/100, reflecting increased financial risk.

Liquidity

Revvity Inc's current ratio of 1.68 indicates adequate short-term liquidity, earning a score of 48/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Revvity Inc converts 17.8% of revenue into free cash flow ($509.4M). This strong cash generation earns a score of 79/100.

Returns

Revvity Inc's ROE of 3.3% shows moderate profitability relative to equity, earning a score of 47/100. This is down from 3.5% the prior year.

Altman Z-Score Grey Zone

2.88

Revvity Inc scores 2.88, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($14.5B) relative to total liabilities ($4.9B). This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/8

Revvity Inc passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.42x

For every $1 of reported earnings, Revvity Inc generates $2.42 in operating cash flow ($582.9M OCF vs $241.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

3.87x

Revvity Inc earns $3.87 in operating income for every $1 of interest expense ($356.6M vs $92.2M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.9B

YoY+3.7%

5Y CAGR-5.5%

10Y CAGR+3.1%

Revvity Inc generated $2.9B in revenue in fiscal year 2025. This represents an increase of 3.7% from the prior year.

EBITDA

$762.0M

YoY-1.6%

5Y CAGR-6.5%

10Y CAGR+7.9%

Revvity Inc's EBITDA was $762.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1.6% from the prior year.

Net Income

$241.2M

YoY-10.8%

5Y CAGR-19.8%

10Y CAGR+1.3%

Revvity Inc reported $241.2M in net income in fiscal year 2025. This represents a decrease of 10.8% from the prior year.

EPS (Diluted)

$2.07

YoY-5.9%

5Y CAGR-20.4%

10Y CAGR+1.0%

Revvity Inc earned $2.07 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 5.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$509.4M

YoY-6.0%

5Y CAGR-9.3%

10Y CAGR+7.0%

Revvity Inc generated $509.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 6.0% from the prior year.

Cash & Debt

$919.9M

YoY-20.9%

5Y CAGR+18.9%

10Y CAGR+14.5%

Revvity Inc held $919.9M in cash against $2.6B in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.28

YoY0.0%

Revvity Inc paid $0.28 per share in dividends in fiscal year 2025. That is unchanged from the prior year.

Shares Outstanding

112M

YoY-7.0%

5Y CAGR0.0%

10Y CAGR+0.2%

Revvity Inc had 112M shares outstanding in fiscal year 2025. This represents a decrease of 7.0% from the prior year.

Margins & Returns

Operating Margin

12.5%

YoY-0.1pp

5Y CAGR-10.4pp

10Y CAGR+0.6pp

Revvity Inc's operating margin was 12.5% in fiscal year 2025, reflecting core business profitability. This is down 0.1 percentage points from the prior year.

Net Margin

8.5%

YoY-1.4pp

5Y CAGR-10.8pp

10Y CAGR-1.6pp

Revvity Inc's net profit margin was 8.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.4 percentage points from the prior year.

Return on Equity

3.3%

YoY-0.2pp

5Y CAGR-16.2pp

10Y CAGR-6.7pp

Revvity Inc's ROE was 3.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.2 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Capital Allocation

R&D Spending

$215.8M

YoY+9.7%

5Y CAGR+8.1%

10Y CAGR+6.7%

Revvity Inc invested $215.8M in research and development in fiscal year 2025. This represents an increase of 9.7% from the prior year.

Share Buybacks

$820.8M

YoY+122.1%

5Y CAGR+159.7%

10Y CAGR+26.8%

Revvity Inc spent $820.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 122.1% from the prior year.

Capital Expenditures

$73.5M

YoY-15.1%

5Y CAGR+2.9%

10Y CAGR+10.0%

Revvity Inc invested $73.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 15.1% from the prior year.

RVTY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

RVTY quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$2.9B	$2.9B+3.7%	$2.8B+0.2%	$2.8B-16.9%	$3.3B-13.5%	$3.8B+1.2%	$3.8B+31.2%	$2.9B+3.8%	$2.8B+23.1%	$2.3B+6.7%	$2.1B+0.5%	$2.1B-5.9%	$2.2B+3.7%	$2.2B+2.0%	$2.1B+10.3%	$1.9B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.4B+102.8%	$708.7M+6.6%	$664.8M-4.5%	$696.5M-1.6%	$708.0M-9.6%	$783.6M+2.7%	$763.0M+11.1%	$686.8M
Gross Profit	N/A	N/A	N/A	N/A	$2.0B-18.2%	$2.4B+15.4%	$2.1B+51.1%	$1.4B+4.1%	$1.3B+24.9%	$1.1B+6.0%	$1.0B+5.1%	$964.2M-4.0%	$1.0B+2.9%	$976.1M+1.3%	$963.2M+13.6%	$847.8M
R&D Expenses	$215.8M	$215.8M+9.7%	$196.8M-9.1%	$216.6M-2.3%	$221.6M+10.6%	$200.3M+36.8%	$146.4M-22.7%	$189.3M-2.4%	$194.0M+39.1%	$139.5M+12.3%	$124.2M+10.3%	$112.5M+4.1%	$108.1M-18.4%	$132.4M+0.4%	$131.8M+13.8%	$115.8M
SG&A Expenses	$1.0B	$991.9M-0.2%	$994.1M-2.8%	$1.0B-0.3%	$1.0B+5.2%	$975.2M+36.1%	$716.5M-12.1%	$815.3M+0.4%	$811.9M+29.7%	$626.0M+6.0%	$590.5M+0.6%	$587.2M-9.4%	$648.2M+11.4%	$581.9M-7.2%	$627.4M+0.5%	$624.4M
Operating Income	$358.8M	$356.6M+2.9%	$346.7M+15.4%	$300.6M-59.5%	$742.7M-41.0%	$1.3B+45.1%	$867.3M+139.6%	$362.0M+11.8%	$323.9M+9.6%	$295.6M+0.4%	$294.6M+17.4%	$250.9M+52.1%	$165.0M-27.6%	$227.8M+120.9%	$103.1M+13.2%	$91.1M
Interest Expense	$94.0M	$92.2M-4.3%	$96.3M-2.6%	$98.8M-4.9%	$104.0M	N/A	$49.7M-21.9%	$63.6M-5.0%	$67.0M+52.4%	$43.9M+5.8%	$41.5M+9.3%	$38.0M+4.8%	$36.3M-27.3%	$49.9M+9.0%	$45.8M+84.8%	$24.8M
Income Tax	$23.4M	$28.4M-14.1%	$33.1M+851.8%	$3.5M-97.5%	$139.2M-55.7%	$314.1M+85.3%	$169.5M+1705.4%	$9.4M-53.5%	$20.2M-85.5%	$139.8M+393.0%	$28.4M+41.7%	$20.0M+419.3%	-$6.3M+40.7%	-$10.6M+34.4%	-$16.1M-125.5%	$63.2M
Net Income	$237.6M	$241.2M-10.8%	$270.4M-61.0%	$693.1M+21.8%	$569.2M-39.7%	$943.2M+29.6%	$727.9M+219.9%	$227.6M-4.4%	$237.9M-18.7%	$292.6M+24.9%	$234.3M+10.3%	$212.4M+34.6%	$157.8M-5.6%	$167.2M+139.1%	$69.9M+813.7%	$7.7M
EPS (Diluted)	$2.09	$2.07-5.9%	$2.20-60.4%	$5.55+23.3%	$4.50-44.3%	$8.08+24.5%	$6.49+218.1%	$2.04-4.2%	$2.13-19.3%	$2.64+24.5%	$2.12+13.4%	$1.87+34.5%	$1.39-5.4%	$1.47+141.0%	$0.61+771.4%	$0.07

Metric	Q3'26	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$729.7M+2.6%	$711.1M-7.9%	$772.1M+10.5%	$698.9M-3.0%	$720.3M+8.4%	$664.8M-8.9%	$729.4M+6.6%	$684.0M
Cost of Revenue	$312.8M-3.3%	$323.5M	N/A	$324.3M-1.0%	$327.7M+13.3%	$289.2M	N/A	$299.2M
Gross Profit	$416.9M+7.5%	$387.7M	N/A	$374.6M-4.6%	$392.6M+4.5%	$375.5M	N/A	$384.8M
R&D Expenses	$49.0M-15.4%	$57.9M-0.5%	$58.2M+14.5%	$50.8M-4.6%	$53.3M-0.6%	$53.6M+8.9%	$49.2M+0.1%	$49.1M
SG&A Expenses	$278.6M+9.7%	$253.9M+0.9%	$251.7M+4.1%	$241.9M-2.7%	$248.5M-0.5%	$249.7M+2.2%	$244.3M+2.9%	$237.5M
Operating Income	$89.3M+17.7%	$75.9M-32.1%	$111.7M+36.5%	$81.9M-9.8%	$90.8M+25.7%	$72.2M-39.2%	$118.8M+21.0%	$98.2M
Interest Expense	$23.0M-7.0%	$24.7M+5.1%	$23.5M+3.3%	$22.8M-0.7%	$22.9M-0.1%	$23.0M+0.8%	$22.8M-6.6%	$24.4M
Income Tax	$10.1M+10.5%	$9.1M+316.1%	-$4.2M-149.8%	$8.5M-37.0%	$13.4M+25.3%	$10.7M+73.5%	$6.2M-11.4%	$7.0M
Net Income	$51.8M+27.3%	$40.7M-58.6%	$98.4M+110.8%	$46.7M-13.5%	$53.9M+27.7%	$42.2M-55.4%	$94.6M+0.3%	$94.4M
EPS (Diluted)	$0.47+30.6%	$0.36-58.1%	$0.86+115.0%	$0.40-13.0%	$0.46+31.4%	$0.35-55.1%	$0.78+1.3%	$0.77

RVTY Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

RVTY quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$12.2B-1.8%	$12.4B-8.6%	$13.6B-4.0%	$14.1B-5.8%	$15.0B+88.4%	$8.0B+21.7%	$6.5B+9.4%	$6.0B-1.9%	$6.1B+42.4%	$4.3B+2.6%	$4.2B+0.9%	$4.1B+4.6%	$3.9B+1.2%	$3.9B+1.2%	$3.9B
Current Assets	$2.2B-4.7%	$2.3B-21.7%	$3.0B-8.7%	$3.3B+34.7%	$2.4B+9.0%	$2.2B+62.9%	$1.4B+11.3%	$1.2B+2.9%	$1.2B+0.8%	$1.2B+15.2%	$1.0B-3.3%	$1.1B+2.3%	$1.0B+7.5%	$971.8M+10.0%	$883.1M
Cash & Equivalents	$919.9M-20.9%	$1.2B+27.4%	$913.2M+101.0%	$454.4M-24.7%	$603.3M+55.9%	$387.1M+101.7%	$191.9M+17.6%	$163.1M-19.3%	$202.1M-43.7%	$359.3M+51.0%	$237.9M+36.1%	$174.8M0.0%	$174.8M+0.9%	$173.2M+21.7%	$142.3M
Inventory	$379.5M+3.2%	$367.6M-14.1%	$428.1M+5.6%	$405.5M-4.8%	$425.9M-17.2%	$514.6M+44.2%	$356.9M+5.5%	$338.3M-3.8%	$351.7M+42.5%	$246.8M-4.9%	$259.5M-9.1%	$285.5M+9.4%	$260.9M+5.3%	$247.7M+2.9%	$240.8M
Accounts Receivable	$744.7M+17.8%	$632.4M-0.1%	$632.8M+3.3%	$612.8M-13.4%	$707.9M-38.7%	$1.2B+59.3%	$725.2M+14.6%	$632.7M+14.6%	$552.3M+29.8%	$425.6M+2.5%	$415.1M-11.8%	$470.6M+0.8%	$466.7M+2.1%	$457.0M+11.5%	$409.9M
Goodwill	$6.6B+2.3%	$6.5B-1.1%	$6.5B+0.8%	$6.5B-2.2%	$6.6B+151.1%	$2.6B-15.2%	$3.1B+5.4%	$3.0B-1.7%	$3.0B+33.6%	$2.2B+0.5%	$2.2B-0.3%	$2.2B+4.7%	$2.1B+1.0%	$2.1B+1.4%	$2.1B
Total Liabilities	$4.9B+4.1%	$4.7B-17.0%	$5.7B-15.6%	$6.7B-14.2%	$7.9B+86.0%	$4.2B+13.4%	$3.7B+9.9%	$3.4B-5.5%	$3.6B+69.0%	$2.1B+3.3%	$2.1B-1.4%	$2.1B+6.8%	$2.0B-0.5%	$2.0B-2.6%	$2.0B
Current Liabilities	$1.3B+103.8%	$653.1M-55.0%	$1.5B-6.1%	$1.5B+27.2%	$1.2B-26.5%	$1.7B+116.6%	$762.8M-1.1%	$771.6M-18.9%	$950.9M+57.6%	$603.4M+7.5%	$561.5M-6.0%	$597.3M-0.9%	$602.8M+3.7%	$581.1M-2.9%	$598.7M
Long-Term Debt	$2.6B-16.5%	$3.2B-0.9%	$3.2B-19.0%	$3.9B-21.2%	$5.0B+209.4%	$1.6B-22.0%	$2.1B+10.0%	$1.9B+4.9%	$1.8B+71.1%	$1.0B+3.3%	$1.0B-3.2%	$1.0B+12.2%	$932.1M-0.7%	$938.8M-0.6%	$944.9M
Total Equity	$7.3B-5.4%	$7.7B-2.6%	$7.9B+6.6%	$7.4B+3.4%	$7.1B+91.2%	$3.7B+32.8%	$2.8B+8.9%	$2.6B+3.3%	$2.5B+16.2%	$2.2B+2.0%	$2.1B+3.3%	$2.0B+2.4%	$2.0B+2.8%	$1.9B+5.3%	$1.8B
Retained Earnings	$6.1B+3.6%	$5.8B+4.2%	$5.6B+13.3%	$5.0B+12.1%	$4.4B+25.9%	$3.5B+24.7%	$2.8B+8.1%	$2.6B+9.3%	$2.4B+12.4%	$2.1B+6.4%	$2.0B+10.0%	$1.8B+7.5%	$1.7B+8.8%	$1.5B+2.5%	$1.5B

Metric	Q3'26	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$12.0B+0.4%	$12.0B-1.4%	$12.2B+0.2%	$12.1B-1.8%	$12.4B0.0%	$12.4B-0.3%	$12.4B-3.0%	$12.8B
Current Assets	$2.3B+8.0%	$2.1B-5.0%	$2.2B+4.5%	$2.1B-4.1%	$2.2B-3.5%	$2.3B-1.3%	$2.3B-4.0%	$2.4B
Cash & Equivalents	$1.0B+18.9%	$860.3M-6.5%	$919.9M-1.2%	$931.4M-6.1%	$991.8M-12.8%	$1.1B-2.2%	$1.2B-5.4%	$1.2B
Inventory	$378.5M-2.3%	$387.5M+2.1%	$379.5M-0.1%	$379.9M-2.2%	$388.5M+1.9%	$381.3M+3.7%	$367.6M-9.1%	$404.6M
Accounts Receivable	$709.2M+2.6%	$691.4M-7.2%	$744.7M+9.5%	$680.3M+2.9%	$661.1M+7.1%	$617.4M-2.4%	$632.4M+5.0%	$602.1M
Goodwill	$6.6B0.0%	$6.6B0.0%	$6.6B+0.2%	$6.6B-0.2%	$6.6B+1.6%	$6.5B+0.7%	$6.5B-1.4%	$6.6B
Total Liabilities	$4.8B+0.1%	$4.8B-2.1%	$4.9B+3.3%	$4.8B-0.9%	$4.8B+1.8%	$4.7B0.0%	$4.7B-2.5%	$4.8B
Current Liabilities	$1.3B+3.0%	$1.2B-7.0%	$1.3B+8.9%	$1.2B+82.0%	$671.8M+3.6%	$648.2M-0.8%	$653.1M-5.1%	$687.9M
Long-Term Debt	$2.6B0.0%	$2.6B0.0%	$2.6B0.0%	$2.6B-18.2%	$3.2B+1.4%	$3.2B+0.6%	$3.2B-1.1%	$3.2B
Total Equity	$7.2B+0.6%	$7.2B-0.9%	$7.3B-1.7%	$7.4B-2.4%	$7.6B-1.1%	$7.6B-0.4%	$7.7B-3.2%	$7.9B
Retained Earnings	$6.1B+0.7%	$6.1B+0.5%	$6.1B+1.5%	$6.0B+0.7%	$5.9B+0.8%	$5.9B+0.6%	$5.8B+1.5%	$5.8B

RVTY Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

RVTY quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$627.6M	$582.9M-7.2%	$628.3M+588.4%	$91.3M-86.6%	$679.8M-51.8%	$1.4B+58.1%	$892.2M+145.5%	$363.5M+16.9%	$311.0M+7.8%	$288.5M-17.7%	$350.6M+22.1%	$287.1M+2.0%	$281.6M+77.6%	$158.6M+4.2%	$152.2M-32.3%	$224.9M
Capital Expenditures	$69.5M	$73.5M-15.1%	$86.6M+6.5%	$81.4M-5.0%	$85.6M-0.5%	$86.0M+35.2%	$63.6M-16.6%	$76.3M-18.1%	$93.3M+138.6%	$39.1M+23.3%	$31.7M+12.3%	$28.2M+3.9%	$27.2M-30.3%	$39.0M-8.1%	$42.4M+38.6%	$30.6M
Free Cash Flow	$558.1M	$509.4M-6.0%	$541.7M+5369.0%	$9.9M-98.3%	$594.2M-55.1%	$1.3B+59.9%	$828.5M+188.6%	$287.1M+31.8%	$217.8M-12.7%	$249.4M-21.8%	$318.9M+23.2%	$258.9M+1.7%	$254.4M+112.7%	$119.6M+9.0%	$109.8M-43.5%	$194.3M
Investing Cash Flow	-$83.3M	-$17.4M-102.2%	$776.2M-40.9%	$1.3B+1088.7%	-$132.9M+96.8%	-$4.1B-715.2%	-$504.5M-3.5%	-$487.6M-205.0%	-$159.9M+87.4%	-$1.3B-1409.9%	-$83.9M+16.8%	-$100.9M+65.9%	-$295.9M-24334.1%	-$1.2M+98.5%	-$80.3M+91.2%	-$909.9M
Financing Cash Flow	-$503.4M	-$857.5M+24.0%	-$1.1B-19.1%	-$947.1M-43.1%	-$661.8M-122.5%	$2.9B+1550.0%	-$202.9M-35.1%	-$150.1M+16.2%	-$179.2M-122.9%	$782.2M+780.1%	-$115.0M-7.3%	-$107.1M-446.4%	$30.9M+120.1%	-$154.2M-249.1%	-$44.2M-111.1%	$397.2M
Dividends Paid	$31.6M	$32.8M-4.8%	$34.5M-1.5%	$35.0M-1.1%	$35.3M+9.2%	$32.4M+3.7%	$31.2M+0.5%	$31.1M+0.2%	$31.0M+0.7%	$30.8M0.0%	$30.8M-2.4%	$31.6M-0.2%	$31.6M+0.1%	$31.6M-0.9%	$31.9M+0.2%	$31.8M
Share Buybacks	$475.8M	$820.8M+122.1%	$369.6M-5.0%	$388.9M+382.3%	$80.6M+10.4%	$73.1M+952.3%	$6.9M+10.0%	$6.3M-89.0%	$57.4M+1398.3%	$3.8M-97.5%	$151.8M+98.6%	$76.4M+16.6%	$65.5M-48.6%	$127.4M+5955.0%	$2.1M-98.1%	$110.0M

Metric	Q3'26	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$191.9M+66.6%	$115.2M-36.7%	$182.0M+31.4%	$138.5M+3.1%	$134.3M+4.8%	$128.2M-26.4%	$174.2M+17.8%	$147.9M
Capital Expenditures	$11.1M-44.0%	$19.8M-2.0%	$20.2M+9.0%	$18.5M-1.9%	$18.9M+18.1%	$16.0M-34.6%	$24.5M+9.6%	$22.3M
Free Cash Flow	$180.9M+89.5%	$95.5M-41.0%	$161.8M+34.8%	$120.0M+3.9%	$115.5M+2.9%	$112.2M-25.1%	$149.8M+19.3%	$125.6M
Investing Cash Flow	-$3.5M+95.5%	-$78.3M-282.7%	-$20.5M-207.8%	$19.0M+299.8%	-$9.5M-48.8%	-$6.4M+63.2%	-$17.3M-102.5%	$690.2M
Financing Cash Flow	-$23.2M+73.9%	-$88.9M+49.6%	-$176.3M+18.0%	-$215.1M+28.9%	-$302.5M-84.8%	-$163.7M+15.2%	-$193.0M+77.9%	-$873.7M
Dividends Paid	$7.8M-0.3%	$7.8M-1.4%	$8.0M-0.2%	$8.0M-1.2%	$8.1M-4.3%	$8.4M-1.2%	$8.5M-0.1%	$8.5M
Share Buybacks	$16.0M-81.5%	$86.5M-48.6%	$168.3M-17.9%	$205.0M-30.2%	$293.9M+91.4%	$153.6M-17.0%	$185.2M+20.1%	$154.1M

RVTY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

RVTY quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	N/A	N/A	N/A	60.1%-3.5pp	63.6%+7.8pp	55.8%+7.4pp	48.4%+0.1pp	48.3%+0.7pp	47.6%-0.3pp	47.9%+2.1pp	45.8%+0.9pp	44.9%-0.3pp	45.2%-0.3pp	45.5%+1.4pp	44.2%
Operating Margin	12.5%-0.1pp	12.6%+1.7pp	10.9%-11.5pp	22.4%-10.4pp	32.9%+9.9pp	22.9%+10.4pp	12.6%+0.9pp	11.7%-1.4pp	13.1%-0.8pp	13.9%+2.0pp	11.9%+4.5pp	7.4%-3.2pp	10.6%+5.7pp	4.9%+0.1pp	4.8%
Net Margin	8.5%-1.4pp	9.8%-15.4pp	25.2%+8.0pp	17.2%-7.5pp	24.6%+5.4pp	19.2%+11.3pp	7.9%-0.7pp	8.6%-4.4pp	13.0%+1.9pp	11.1%+1.0pp	10.1%+3.0pp	7.0%-0.7pp	7.8%+4.4pp	3.3%+2.9pp	0.4%
Return on Equity	3.3%-0.2pp	3.5%-5.3pp	8.8%+1.1pp	7.7%-5.5pp	13.2%-6.3pp	19.5%+11.4pp	8.1%-1.1pp	9.2%-2.5pp	11.7%+0.8pp	10.9%+0.8pp	10.1%+2.3pp	7.7%-0.7pp	8.4%+4.8pp	3.6%+3.2pp	0.4%
Return on Assets	2.0%-0.2pp	2.2%-2.9pp	5.1%+1.1pp	4.0%-2.3pp	6.3%-2.8pp	9.1%+5.7pp	3.5%-0.5pp	4.0%-0.8pp	4.8%-0.7pp	5.5%+0.4pp	5.1%+1.3pp	3.8%-0.4pp	4.2%+2.5pp	1.8%+1.6pp	0.2%
Current Ratio	1.68-1.9x	3.60+1.5x	2.07-0.1x	2.13+0.1x	2.01+0.7x	1.36-0.4x	1.80+0.2x	1.60+0.3x	1.26-0.7x	1.97+0.1x	1.84+0.1x	1.79+0.1x	1.73+0.1x	1.67+0.2x	1.48
Debt-to-Equity	0.360.0x	0.410.0x	0.40-0.1x	0.53-0.2x	0.70+0.3x	0.43-0.3x	0.730.0x	0.730.0x	0.71+0.2x	0.490.0x	0.480.0x	0.510.0x	0.470.0x	0.480.0x	0.51
FCF Margin	17.8%-1.8pp	19.7%+19.3pp	0.4%-17.6pp	17.9%-16.7pp	34.6%+12.7pp	21.9%+11.9pp	10.0%+2.1pp	7.8%-3.2pp	11.1%-4.0pp	15.1%+2.8pp	12.3%+0.9pp	11.4%+5.8pp	5.5%+0.3pp	5.2%-4.9pp	10.1%

Metric	Q3'26	Q2'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	57.1%+2.6pp	54.5%	N/A	53.6%-0.9pp	54.5%-2.0pp	56.5%	N/A	56.3%
Operating Margin	12.2%+1.6pp	10.7%-3.8pp	14.5%+2.7pp	11.7%-0.9pp	12.6%+1.7pp	10.9%-5.4pp	16.3%+1.9pp	14.3%
Net Margin	7.1%+1.4pp	5.7%-7.0pp	12.7%+6.1pp	6.7%-0.8pp	7.5%+1.1pp	6.3%-6.6pp	13.0%-0.8pp	13.8%
Return on Equity	0.7%+0.1pp	0.6%-0.8pp	1.4%+0.7pp	0.6%-0.1pp	0.7%+0.2pp	0.5%-0.7pp	1.2%0.0pp	1.2%
Return on Assets	0.4%+0.1pp	0.3%-0.5pp	0.8%+0.4pp	0.4%-0.1pp	0.4%+0.1pp	0.3%-0.4pp	0.8%0.0pp	0.7%
Current Ratio	1.80+0.1x	1.720.0x	1.68-0.1x	1.75-1.6x	3.33-0.2x	3.580.0x	3.600.0x	3.56
Debt-to-Equity	0.360.0x	0.370.0x	0.360.0x	0.36-0.1x	0.430.0x	0.410.0x	0.410.0x	0.40
FCF Margin	24.8%+11.4pp	13.4%-7.5pp	21.0%+3.8pp	17.2%+1.1pp	16.0%-0.8pp	16.9%-3.7pp	20.5%+2.2pp	18.4%

Similar Companies

Qiagen QGEN

$9.0B

Charles Riv Labs Intl Inc CRL

$14.1B

Guardant Health GH

$22.9B

Radnet RDNT

$6.0B

Sotera Health Co SHC

$5.6B

Where Revvity Inc Ranks

Frequently Asked Questions

What is Revvity Inc's annual revenue?

Revvity Inc (RVTY) reported $2.9B in total revenue for fiscal year 2025. This represents a 3.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Revvity Inc's revenue growing?

Revvity Inc (RVTY) revenue grew by 3.7% year-over-year, from $2.8B to $2.9B in fiscal year 2025.

Is Revvity Inc profitable?

Yes, Revvity Inc (RVTY) reported a net income of $241.2M in fiscal year 2025, with a net profit margin of 8.5%.

What is Revvity Inc's EBITDA?

Revvity Inc (RVTY) had EBITDA of $762.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Revvity Inc have?

As of fiscal year 2025, Revvity Inc (RVTY) had $919.9M in cash and equivalents against $2.6B in long-term debt.

What is Revvity Inc's operating margin?

Revvity Inc (RVTY) had an operating margin of 12.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Revvity Inc's net profit margin?

Revvity Inc (RVTY) had a net profit margin of 8.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Revvity Inc pay dividends?

Yes, Revvity Inc (RVTY) paid $0.28 per share in dividends during fiscal year 2025.

What is Revvity Inc's return on equity (ROE)?

Revvity Inc (RVTY) has a return on equity of 3.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Revvity Inc's free cash flow?

Revvity Inc (RVTY) generated $509.4M in free cash flow during fiscal year 2025. This represents a -6.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Revvity Inc's operating cash flow?

Revvity Inc (RVTY) generated $582.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Revvity Inc's total assets?

Revvity Inc (RVTY) had $12.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Revvity Inc's capital expenditures?

Revvity Inc (RVTY) invested $73.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Revvity Inc spend on research and development?

Revvity Inc (RVTY) invested $215.8M in research and development during fiscal year 2025.

Does Revvity Inc buy back shares?

Yes, Revvity Inc (RVTY) spent $820.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Revvity Inc have outstanding?

Revvity Inc (RVTY) had 112M shares outstanding as of fiscal year 2025.

What is Revvity Inc's current ratio?

Revvity Inc (RVTY) had a current ratio of 1.68 as of fiscal year 2025, which is generally considered healthy.

What is Revvity Inc's debt-to-equity ratio?

Revvity Inc (RVTY) had a debt-to-equity ratio of 0.36 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Revvity Inc's return on assets (ROA)?

Revvity Inc (RVTY) had a return on assets of 2.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Revvity Inc's Altman Z-Score?

Revvity Inc (RVTY) has an Altman Z-Score of 2.88, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Revvity Inc's Piotroski F-Score?

Revvity Inc (RVTY) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Revvity Inc's earnings high quality?

Revvity Inc (RVTY) has an earnings quality ratio of 2.42x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Revvity Inc cover its interest payments?

Revvity Inc (RVTY) has an interest coverage ratio of 3.87x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Revvity Inc?

Revvity Inc (RVTY) scores 52 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.